|
1
|
2 UNIDADES.- DISSOLUTION PERFORMANCE VERIFICATION STANDARD - PREDNISONE (30 TABLETS)
|
-NOT AVAILABLE-
|
USP- UNITED STATES PHARMACOPEIAL CONVENTION
|
2025-10-14
|
SPAIN
|
0.12 Kgs
|
0.08 0
|
|
2
|
1 UNIDAD.- PROPRANOLOL HYDROCHLORIDE (200 MG)
|
-NOT AVAILABLE-
|
USP- UNITED STATES PHARMACOPEIAL CONVENTION
|
2025-10-14
|
UNITED KINGDOM
|
0.15 Kgs
|
0.1 0
|
|
3
|
3 UNIDADES.- VITAMIN D ASSAY SYSTEM SUITABILITY
|
-NOT AVAILABLE-
|
USP- UNITED STATES PHARMACOPEIAL CONVENTION
|
2025-10-14
|
INDIA
|
0.15 Kgs
|
0.1 0
|
|
4
|
1 UNIDAD.- NAPROXEN RELATED COMPOUND L (15 MG) (1-(6-METHOXYNAPHTHALEN-2-YL)ETHANONE
|
-NOT AVAILABLE-
|
USP- UNITED STATES PHARMACOPEIAL CONVENTION
|
2025-10-14
|
INDIA
|
0.15 Kgs
|
0.1 0
|
|
5
|
1 UNIDAD.- NAPROXEN RELATED COMPOUND K (50 MG) (1-(6-METHOXYNAPHTHALEN-2-YL)ETHANOL)
|
-NOT AVAILABLE-
|
USP- UNITED STATES PHARMACOPEIAL CONVENTION
|
2025-10-14
|
INDIA
|
0.15 Kgs
|
0.1 0
|
|
6
|
1 UNIDAD.- NAPROXEN RELATED COMPOUND G (50 MG)
|
-NOT AVAILABLE-
|
USP- UNITED STATES PHARMACOPEIAL CONVENTION
|
2025-10-14
|
INDIA
|
0.15 Kgs
|
0.1 0
|
|
7
|
1 UNIDAD.- NAPROXEN RELATED COMPOUND E (25 MG)
|
-NOT AVAILABLE-
|
USP- UNITED STATES PHARMACOPEIAL CONVENTION
|
2025-10-14
|
INDIA
|
0.15 Kgs
|
0.1 0
|
|
8
|
1 UNIDAD.- NAPROXEN RELATED COMPOUND A (20 MG) (6-METHOXY-2-NAPHTHOIC ACID)
|
-NOT AVAILABLE-
|
USP- UNITED STATES PHARMACOPEIAL CONVENTION
|
2025-10-14
|
CHINA
|
0.15 Kgs
|
0.1 0
|
|
9
|
1 UNIDAD.- NAPROXEN (200 MG)
|
-NOT AVAILABLE-
|
USP- UNITED STATES PHARMACOPEIAL CONVENTION
|
2025-10-14
|
INDIA
|
0.15 Kgs
|
0.1 0
|
|
10
|
1 UNIDAD.- CITICOLINE SODIUM (2 X 350 ML)
|
-NOT AVAILABLE-
|
USP- UNITED STATES PHARMACOPEIAL CONVENTION
|
2025-10-14
|
SPAIN
|
0.15 Kgs
|
0.1 0
|